FILTER

FILTERED INTERVIEW RESULTS

Luca Crippa

CEO & MANAGING DIRECTOR, IBSA FARMACEUTICI
Instituto Biochimico, with 2,000 global employees, is attempting to take generics to the next level and continue to expand around the world.

Franco Lori

CEO & FOUNDER, VIROSTATICS
Virostatics is a private drug discovery and development company focused on NCEs used in the treatment of cancers and viral diseases.

Brian Frenzel

PRESIDENT & CEO, TOSK
Tosk explains how it is successfully developing drugs to counter the side effects of cancer therapies.

Prasad Raje

CEO, LGM PHARMA
LGM Pharma explains how working with a smaller CDMO with extensive experience and partnerships can be beneficial.

Ramin Cyrus

VICE PRESIDENT MARKETING, LONZA CAPSULES AND HEALTH INGREDIENTS
Lonza Capsules and Health Ingredients comments on market trends.

Vivek Sharma

CEO, ADARE PHARMA SOLUTIONS
Adare Pharma Solutions explains how it is expanding its range as a leading technology-driven CDMO.

John Huang

CEO, THEWELL BIOSCIENCE
TheWell Bioscience is a biomedical technology company providing innovative 3D cell platforms for drug discovery, cell therapy and personalized medicine.

Cosimo Lenti

BUSINESS DIRECTOR, DIATHEVA
Diatheva promotes biotechnological innovation by providing high-value customized diagnostic kits and solutions.

Gilda D'Incerti

CEO AND FOUNDER, PQE GROUP
PQE Group explains its imperative to expand rapidly apace with the global life science industry.

Robert Bloder

CHIEF BUSINESS OFFICER, ASCENDIA PHARMACEUTICALS
Ascendia Pharmaceuticals recounts the requirements to succeed in the CDMO space.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2024 - Pre-release

The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.

PARTNER EVENTS